DMKPQ Insider Holders & Insider Ownership - DMK PHARMACEUTICALS CORP COM P

List of insiders holdings for DMK PHARMACEUTICALS CORP COM P:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
GREGORY JOHN M SJ STRATEGIC INVESTMENTS LLC GREGORY JOAN P GREGORY JAMES M PALMER SUSAN 10% Owner	2008-12-17 12:06:18	0 7,053,993	7,053,993	Form 4/A
Aloi Richard L Director	2009-04-13 18:01:37	3,593,039 0	3,593,039	Form 3
Rahman Ahmed Shayan Fazlur Eses Holdings (FZE) 10% Owner	2017-09-25 16:30:24	1,635,315 0	1,635,315	Form 13D
TISCH JAMES S 10% Owner	2004-07-29 18:46:05	370,378 764,508	1,134,886	Form 4
TISCH DANIEL R 10% Owner	2004-07-29 18:46:34	370,378 764,508	1,134,886	Form 4
TISCH ANDREW H 10% Owner	2004-07-29 18:47:16	370,378 764,508	1,134,886	Form 4
Versi Ebrahim CEO	2023-09-19 17:17:24	8,745 907,606	916,351	Form 4
Glover Eddie Wabern CEO of US Compounding, Inc.	2019-02-12 18:44:53	741,668 0	741,668	Form 5
CARLO DENNIS J PHD Former President & CEO	2022-05-27 16:07:12	535,867 156,592	692,459	Form 4
Hopkins Robert O Chief Financial Officer	2021-02-23 19:07:26	277,067 0	277,067	Form 4
WILLIAMS RICHARD C Director	2019-05-28 18:12:47	239,918 0	239,918	Form 4
Marguglio David J. SVP and Chief Business Officer	2022-03-22 18:39:00	233,906 5,884	239,790	Form 4
TISCH THOMAS J 10% Owner	2010-02-16 16:59:50	206,885 0	206,885	Form 13D
Versi Jannine Director	2023-05-30 18:14:44	25,720 179,135	204,855	Form 4
Moss Ronald B. Chief Medical Officer	2022-03-22 18:39:54	201,911 0	201,911	Form 4
Daniels Karen K. VP of Operations	2021-02-16 19:48:53	163,153 0	163,153	Form 5
COHEN SETH CFO	2023-10-25 17:18:34	151,416 0	151,416	Form 4
ROTHERMEL ROBERT B Director	2019-05-28 18:11:42	133,500 0	133,500	Form 4
Moll Thomas VP of Research	2018-02-23 17:53:23	125,200 0	125,200	Form 4
STEIGROD ALAN A Director	2003-11-10 20:54:49	110,556 0	110,556	Form 4
DENBY WILLIAM C Director	2019-05-28 18:13:51	108,750 0	108,750	Form 4
BOWMAN JACK L Director	2003-11-10 20:53:02	101,806 0	101,806	Form 4
Caso Robert J VP, Finance & CFO	2005-04-07 19:20:54	100,000 0	100,000	Form 4
WELLS LARRY J Director	2003-11-13 19:03:08	99,114 0	99,114	Form 4
SALDARINI RONALD J Director	2003-11-10 17:29:04	79,194 0	79,194	Form 4
Dorbin John W. Jr. General Counsel	2023-11-02 16:50:52	70,000 0	70,000	Form 4
BIRNDORF HOWARD C Director	2022-11-16 16:41:21	58,824 0	58,824	Form 4
Blunt Roshawn A. Director	2020-02-13 16:21:25	50,000 0	50,000	Form 4
ADAMS JOHN Q Director	2009-04-08 12:32:49	50,000 0	50,000	Form 4
Benedicto David C. Chief Financial Officer	2022-03-22 18:35:18	39,875 0	39,875	Form 4
Nova Tina Susan Director	2013-10-17 17:01:22	35,000 0	35,000	Form 4
Cohen Kenneth M Director	2013-10-17 16:59:38	35,000 0	35,000	Form 4
Johnson Craig A Director	2013-10-17 16:58:21	35,000 0	35,000	Form 4
STEINBERG THOMAS M Director	2005-11-21 21:49:32	12,000 0	12,000	Form 4
KLAR TOBI B Director	2005-11-21 21:44:04	12,000 0	12,000	Form 4
Corner Anne-Marie Senior Vice President	2005-06-21 17:25:50	10,277 0	10,277	Form 4
CHANDLER JOHN J VP, Corporate Development	2005-11-21 21:44:05	10,000 0	10,000	Form 4
JUELIS A RICHARD Vice President	2004-11-05 17:01:52	6,820 0	6,820	Form 4
Desai Meera J. Director	2023-05-30 18:15:16	3,138 0	3,138	Form 4
REED VICKIE S Director	2022-05-26 16:28:33	0 0	0	Form 3
KARLIN DAVID A VP, Clinical Research	2004-12-29 14:23:12	0 0	0	Form 4

Insider Holders & Insider Ownership - DMK PHARMACEUTICALS CORP COM P (DMKPQ)